Personalized ILD care aims to boost quality of life

NCT ID NCT06626438

First seen Oct 31, 2025 · Last updated May 12, 2026 · Updated 24 times

Summary

This study tests a personalized treatment approach called 'treatable traits' for people with interstitial lung disease (ILD). Researchers want to see if this tailored care—including visits with a doctor, physiotherapist, psychologist, and dietitian—improves quality of life, symptoms, and physical activity compared to standard care. About 110 adults with fibrotic ILD will take part, completing surveys, lung tests, and body scans.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASES (ILD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fiona Stanley Hospital

    RECRUITING

    Perth, Western Australia, 6150, Australia

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Sir Charles Gairdner Hospital

    NOT_YET_RECRUITING

    Perth, Western Australia, 6009, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.